fig1
![Prognostic factors and efficacy of GDP-R therapy in refractory/relapsed diffuse large B-cell lymphomas not eligible for high-dose therapy](https://image.oaes.cc/4763499e-85fa-4c91-be99-71fe01ea783f/1300.fig.1.png)
Figure 1. Time to treatment failure curves according to the number of previous chemotherapeutic regiments
Figure 1. Time to treatment failure curves according to the number of previous chemotherapeutic regiments
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/